Scabies Affects Quality of Life in Correlation with Depression and Anxiety

Citation: Koç Yıldırım S, Demirel Öğüt N, Erbağcı E, Öğüt Ç. Scabies Affects Quality of Life in Correlation with Depression and Anxiety. Dermatol Pract Concept. 2023;13(2):e2023144. DOI: https://doi.org/10.5826/dpc.1302a144

Accepted: November 3, 2022; Published: April 2023

Copyright: ©2023 Koç Yıldırım et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited.

Funding: None.

Competing interests: None.

Authorship: All authors have contributed significantly to this publication.

Corresponding author: Dr. Sema Koç Yıldırım; Uşak University Training and Research Hospital, Department of Dermatology and Venereology, Uşak, Turkey; Tel: +90 536 7371594; e-mail: semakocyildirim@gmail.com

Abstract

Introduction: Scabies is a highly contagious disease affects many people worldwide each year and a major public health problem. A small number of studies have shown that scabies causes impairment in the quality of life in adult patients.

Objectives: The aims of this study are to assess the impact of scabies on adult patients quality of life (QoL) and evaluate the relationship between depression and anxiety levels and impairment in life quality.

Methods: This cross-sectional study included adult patients diagnosed with scabies in our dermatology outpatient clinic. The effect of scabies on QoL was evaluated by Dermatology Life Quality Index (DLQI), and the levels of depression and anxiety were evaluated by Beck Depression Scale (BDS) and Beck Anxiety Scale (BAS).

Results: Totally, 85 patients included to the study. QoL of 72.2% of the patients was moderate to extremely large affected. There was a positive correlation between the duration of the disease, the total DLQI score and the severity of the disease impact on QoL (r_s= 0.287,  P = 0.01 and r_s=0.280, P = 0.008, respectively). A positive correlation was found between the number of treatments received and the total DLQI (r_s= 0.223, P = 0.042). There was a positive correlation between BDS and BAS, and total DLQI score (r_s=0.448 and P = 0.000; rs=0.456 and P = 0.000, respectively).

Conclusions: Scabies has a moderate to severe effect on QoL. There was a positive correlation between impairment QoL and anxiety and depression scores.

Keywords : scabies, quality of life, Dermatology Life Quality Index, depression, anxiety

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

1. Vos T, Abajobir AA, Abbafati C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2 2. Cox V, Fuller LC, Engelman D, Steer A, Hay RJ. Estimating the global burden of scabies: what else do we need? Br J Dermatol. 2021;184(2):237-242. doi:10.1111/BJD.19170 3. Collinson S, Timothy J, Zayzay SK, et al. The prevalence of scabies in Monrovia, Liberia: A population-based survey. PLoS Negl Trop Dis. 2020;14(12):e0008943. doi:10.1371/JOURNAL.PNTD.0008943 4. Özden MG, Ertürk K, Kartal SP, et al. An extraordinary outbreak of scabies in Turkey. J Eur Acad Dermatol Venereol. 2020;34(12):e818-e820. doi:10.1111/JDV.16699 5. Jin-Gang A, Sheng-Xiang X, Sheng-Bin X, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol. 2010;24(10):1187-1191. doi:10.1111/J.1468-3083.2010.03618.X 6. Karimkhani C, Colombara D v., Drucker AM, et al. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(12):1247-1254. doi:10.1016/S1473-3099(17)30483-8 7. Ashok Nair PA, Vora RV, Jivani NB, Gandhi SS. A Study of Clinical Profile and Quality of Life in Patients with Scabies at a Rural Tertiary Care Centre. J Clin Diagn Res. 2016;10(10):WC01-WC05. doi:10.7860/JCDR/2016/20938.8703 8. Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Feldmeier H. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012;51(3):275-282. doi:10.1111/J.1365-4632.2011.05017.X 9. Lake SJ, Engelman D, Sokana O, et al. Health-related quality of life impact of scabies in the Solomon Islands. Trans R Soc Trop Med Hyg. 2022;116(2):148-156. doi:10.1093/TRSTMH/TRAB096 10. Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020;183(5):808-820. doi:10.1111/BJD.18943 11. Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31(8):1248-1253. doi:10.1111/JDV.14351 12. Öztürkcan S, Ermertcan AT, Eser E, Turhan Şahin M. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45(11):1300-1307. doi:10.1111/J.1365-4632.2006.02881.X 13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-571. doi:10.1001/ARCHPSYC.1961.01710120031004 14. Hisli N. A study on the validity of Beck depression inventory. . J Psychol (Psikoloji Dergisi) . 1988;6:118-122. 15. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-897. doi:10.1037//0022-006X.56.6.893 16. Ulusoy M, Hisli-Sahin N, Erkmen H. Turkish version of the Beck Anxiety Inventory: psychometric properties. . Journal of cognitive psychotherapy . 1998;12(2):163-undefined. 17. Redondo-Bravo L, Fernandez-Martinez B, Gómez-Barroso D, et al. Scabies in Spain? A comprehensive epidemiological picture. PLoS One. 2021;16(11). doi:10.1371/JOURNAL.PONE.0258780 18. Lugović-Mihić L. The increase in Croatia’s scabies incidence: How did refugees and traveling contribute? Travel Med Infect Dis. 2019;29:74. doi:10.1016/J.TMAID.2019.02.002 19. Sunderkötter C, Aebischer A, Neufeld M, et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019;17(1):15-23. doi:10.1111/DDG.13706 20. Turan Ç, Metin N, Utlu Z. Epidemiological Evaluation of Scabies Cases Encountered in the Last Three Years as a Tertiary Health Center. Turkiye Parazitol Derg. 2020;44(2):77-82. doi:10.4274/TPD.GALENOS.2020.6796 21. Khalil S, Abbas O, Kibbi AG, Kurban M. Scabies in the age of increasing drug resistance. PLoS Negl Trop Dis. 2017;11(11). doi:10.1371/JOURNAL.PNTD.0005920 22. de Sainte Marie B, Mallet S, Gaudy-Marqueste C, et al. [Therapeutic failure in scabies: An observational study]. Ann Dermatol Venereol. 2016;143(1):9-15. doi:10.1016/J.ANNDER.2015.10.588 23. Mazzatenta C, Piccolo V, Argenziano G, Bassi A. Is Scabies becoming less sensitive to permethrin therapy? J Eur Acad Dermatol Venereol. 2021;35(9):e607-e609. doi:10.1111/JDV.17339 24. Akoglu G, Yildiz I, Karaismailoğlu E, Esme P. Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa. Dermatol Ther. 2021;34(3). doi:10.1111/DTH.14910 25. Talamonti M, Galluzzo M, Silvaggio D, Lombardo P, Tartaglia C, Bianchi L. Quality of Life and Psychological Impact in Patients with Atopic Dermatitis. J Clin Med. 2021;10(6):1-9. doi:10.3390/JCM10061298 26. Lee J, Suh H, Jung H, Park M, Ahn J. Association between chronic pruritus, depression, and insomnia: A cross-sectional study. JAAD Int. 2021;3:54-60. doi:10.1016/J.JDIN.2021.02.004 27. Pietrzak D, Pietrzak A, Krasowska D, et al. Depressiveness, measured with Beck Depression Inventory, in patients with psoriasis. J Affect Disord. 2017;209:229-234. doi:10.1016/J.JAD.2016.11.045 28. Misery L, Touboul S, Vinçot C, et al. [Stress and seborrheic dermatitis]. Ann Dermatol Venereol. 2007;134(11):833-837. doi:10.1016/S0151-9638(07)92826-4 29. Taner E, Coşar B, Burhanoǧlu S, Çalikoǧlu E, Önder M, Arikan Z. Depression and anxiety in patients with Behçet’s disease compared with that in patients with psoriasis. Int J Dermatol. 2007;46(11):1118-1124. doi:10.1111/J.1365-4632.2007.03247.X 30. Engin B, Uguz F, Yilmaz E, Özdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology. 2008;22(1):36-40. doi:10.1111/J.1468-3083.2007.02324.X 31. Cole EF, Ojeaga A, Chen S, Swerlick RA. Symptoms of depression and anxiety are associated with poorer functional outcomes in chronic pruritus. J Am Acad Dermatol. 2021;85(3):730-731. doi:10.1016/J.JAAD.2019.06.031